Correction: PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells

Correction: PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-03-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/10/3/e002500corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells
by: Leszek Pączek, et al.
Published: (2022-01-01)

Correction: Targeting and cytotoxicity of chimeric antigen receptor T cells grafted with PD1 extramembrane domain
by: Ang Zhang, et al.
Published: (2025-04-01)

Enhanced cytotoxic activity of effector T-cells against cholangiocarcinoma by dendritic cells pulsed with pooled mRNA
by: Mutita Junking, et al.
Published: (2017-10-01)

Correction: CAR-NK cells with dual targeting of PD-L1 and MICA/B in lung cancer tumor models
by: Lingtong Zhi, et al.
Published: (2025-03-01)

Evaluation of CAR-T cell cytotoxicity against a prostate carcinoma model
by: A.Kh. Valiullina, et al.
Published: (2022-06-01)

Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines
by: Cynthia González Muñoz, et al.
Published: (2025-05-01)

Is immune effector cell-associated enterocolitis a CAR T-cell lymphoproliferative disorder?
by: Kayra Somay, et al.
Published: (2025-07-01)

TARGETING PRC2 ENHANCES THE ANTITUMOR CYTOTOXIC CAPACITY OF ANTI-CD19 CAR-T CELLS AGAINST HEMATOLOGICAL MALIGNANCIES
by: MLR Carvalho, et al.
Published: (2024-10-01)

Repertoire Development and the Control of Cytotoxic/Effector Function in Human γδ T Cells
by: Elizabeth M. Urban, et al.
Published: (2010-01-01)

Engineered PD-L1 co-expression in PD-1 knockout and MAGE-C2-targeting TCR-T cells augments the cytotoxic efficacy toward target cancer cells
by: Fangxin Zhao, et al.
Published: (2025-04-01)

T-bet overexpression enhances CAR T cell effector functions and antigen sensitivity
by: M. Eric Kohler, et al.
Published: (2025-04-01)

A hexamerization-enhanced, Fc-silenced agonistic CD27 antibody amplifies T-cell effector functions as single agent and in combination with PD-1 blockade
by: Işıl Altıntaş, et al.
Published: (2025-07-01)

B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer
by: Giulia Cattaneo, et al.
Published: (2025-08-01)

Infiltration of CD8+ cytotoxic T-cells and expression of PD-1 and PD-L1 in ovarian clear cell carcinoma
by: Mengdi Fu, et al.
Published: (2025-02-01)

Targeting and cytotoxicity of chimeric antigen receptor T cells grafted with PD1 extramembrane domain
by: Ang Zhang, et al.
Published: (2023-09-01)

CAR-NK cells with dual targeting of PD-L1 and MICA/B in lung cancer tumor models
by: Lingtong Zhi, et al.
Published: (2025-02-01)

The safer effector cell? Potential of CD147 CAR NK cells to tackle tumors with lower toxicity
by: Alan Hodges, et al.
Published: (2025-06-01)

Cytotoxic Chemotherapy and CD4+ Effector T Cells: An Emerging Alliance for Durable Antitumor Effects
by: Zhi-Chun Ding, et al.
Published: (2012-01-01)

Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells
by: Methi Wathikthinnakon, et al.
Published: (2022-04-01)

Improved acid-driven inhibition of effector T cell function by a pHLIP variant-conjugated PD-L1
by: Hang Zheng, et al.
Published: (2025-04-01)

Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines
by: Bhumsuk Keam, et al.
Published: (2020-10-01)

Correction: Inhibition of autophagy enhances the antitumor efficacy of T/CAR T cell against neuroblastoma
by: Francesca De Mitri, et al.
Published: (2025-08-01)

Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme.
by: Brittany A Goods, et al.
Published: (2017-01-01)

Cytotoxic granules and effector molecules from immune cells in tuberculosis: Mechanisms of host defense and therapeutic potential
by: Yongwei Qin, et al.
Published: (2025-12-01)

Production of cytokines by cell-effectors of natural cytotoxicity system in mice under development of Lewis lung carcinoma
by: Ye. Yu. Sherstoboyev, et al.
Published: (2004-06-01)

Enhanced cytotoxicity against cholangiocarcinoma by fifth-generation chimeric antigen receptor T cells targeting integrin αvβ6 and secreting anti-PD-L1 scFv
by: Nattaporn Phanthaphol, et al.
Published: (2025-04-01)

Evaluation of In Vitro Cytotoxic Activity of CAR-T Cells Using Patient-Derived Organoids
by: Lei Yu
Published: (2025-07-01)

Correction: HER2 as a Promising Target for Cytotoxicity T Cells in Human Melanoma Therapy
Published: (2013-01-01)

Loss of MNX1 Sensitizes Tumors to Cytotoxic T Cells by Degradation of PD‐L1 mRNA
by: Zhengzheng Li, et al.
Published: (2025-03-01)

Breast cancer patient-derived scaffolds enhance the understanding of PD-L1 regulation and T cell cytotoxicity
by: Elena Garre, et al.
Published: (2025-04-01)

The combination of SH003 and DTX induces cytotoxic cell infiltration in anti-PD1 resistant lung cancer
by: Yu-Jeong Choi, et al.
Published: (2025-05-01)

Correction: Cell death induced by cytotoxic CD8+ T cells is immunogenic and primes caspase-3–dependent spread immunity against endogenous tumor antigens
Published: (2020-05-01)

Efficacy of MET-targeting CAR T cells against glioblastoma patient-derived xenograft models
by: Anna Qin, et al.
Published: (2025-04-01)

The CXCL16/CXCR6 axis is linked to immune effector cell-associated neurotoxicity in chimeric antigen receptor (CAR) T cell therapy
by: I-Na Lu, et al.
Published: (2025-06-01)

The Nuclear Receptor NR1B1/RARα Arrests the Differentiation of Anti‐Tumor Effector Cytotoxic T Cells
by: Patrick Niekamp, et al.
Published: (2025-05-01)

PD-1 is expressed in cytotoxic granules of NK cells and rapidly mobilized to the cell membrane following recognition of tumor cells
by: Cecilia Pesini, et al.
Published: (2022-12-01)

Targeting Aggressive Prostate Carcinoma Cells with Mesothelin-CAR-T Cells
by: Apolline de Testas de Folmont, et al.
Published: (2025-05-01)

Cytotoxicity induced by Aeromonas schubertii is orchestrated by a unique set of type III secretion system effectors
by: Hana Michova, et al.
Published: (2025-06-01)

GD2 targeting CAR T cells for neuroblastoma
by: John Anderson, et al.
Published: (2024-12-01)

Targeted tumor cell-intrinsic CTRP6 biomimetic codelivery synergistically amplifies ferroptosis and immune activation to boost anti-PD-L1 immunotherapy efficacy in lung cancer
by: Songhua Cai, et al.
Published: (2025-06-01)